161 related articles for article (PubMed ID: 35236097)
1. Clinical Impact of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement.
Garcia S; Fukui M; Dworak MW; Okeson BK; Garberich R; Hashimoto G; Sato H; Cavalcante JL; Bapat VN; Lesser J; Cheng V; Newell MC; Goessl M; Elmariah S; Bradley SM; Sorajja P
Circ Cardiovasc Interv; 2022 Mar; 15(3):e011480. PubMed ID: 35236097
[TBL] [Abstract][Full Text] [Related]
2. Deformation of Transcatheter Aortic Valve Prostheses: Implications for Hypoattenuating Leaflet Thickening and Clinical Outcomes.
Fukui M; Bapat VN; Garcia S; Dworak MW; Hashimoto G; Sato H; Gössl M; Enriquez-Sarano M; Lesser JR; Cavalcante JL; Sorajja P
Circulation; 2022 Aug; 146(6):480-493. PubMed ID: 35862182
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Follow-Up of Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement.
Hein M; Schoechlin S; Schulz U; Minners J; Breitbart P; Lehane C; Neumann FJ; Ruile P
JACC Cardiovasc Interv; 2022 Jun; 15(11):1113-1122. PubMed ID: 35680190
[TBL] [Abstract][Full Text] [Related]
4. Gender Differences and Outcomes of Hypoattenuated Leaflet Thickening (HALT) Following Transcatheter Aortic Valve Replacement: A Meta-analysis of Randomized and Cohort Studies.
Salah HM; Almaddah N; Xu J; Al-Hawwas M; Agarwal SK; Uretsky BF; Dhar G; Al'Aref SJ
Curr Probl Cardiol; 2023 Jul; 48(7):101155. PubMed ID: 35192871
[TBL] [Abstract][Full Text] [Related]
5. Bioprosthetic valve oversizing is associated with increased risk of valve thrombosis following TAVR.
Simpson TF; Tuohy CV; Rajotte K; Golwala H; Fuss C; Song HK; Zahr F; Chadderdon SM
Catheter Cardiovasc Interv; 2021 Feb; 97(3):E411-E417. PubMed ID: 32633055
[TBL] [Abstract][Full Text] [Related]
6. Clinical predictors and sequelae of computed tomography defined leaflet thrombosis following transcatheter aortic valve replacement at medium-term follow-up.
Rashid HN; Michail M; Ihdayhid AR; Dowling C; Khav N; Tan S; Ramnarain J; Cameron JD; Nasis A; Nicholls SJ; Gooley RP
Heart Vessels; 2021 Sep; 36(9):1374-1383. PubMed ID: 33660057
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamics and Subclinical Leaflet Thrombosis in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement.
Khan JM; Rogers T; Waksman R; Torguson R; Weissman G; Medvedofsky D; Craig PE; Zhang C; Gordon P; Ehsan A; Wilson SR; Goncalves J; Levitt R; Hahn C; Parikh P; Bilfinger T; Butzel D; Buchanan S; Hanna N; Garrett R; Shults C; Garcia-Garcia HM; Kolm P; Satler LF; Buchbinder M; Ben-Dor I; Asch FM
Circ Cardiovasc Imaging; 2019 Dec; 12(12):e009608. PubMed ID: 31826675
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter Aortic Valve Replacement and Impact of Subclinical Leaflet Thrombosis in Low-Risk Patients: LRT Trial 4-Year Outcomes.
Waksman R; Bhogal S; Gordon P; Ehsan A; Wilson SR; Levitt R; Parikh P; Bilfinger T; Hanna N; Buchbinder M; Asch FM; Kim FY; Weissman G; Ben-Dor I; Shults CC; Ali S; Sutton JA; Shea C; Zhang C; Garcia-Garcia HM; Satler LF; Rogers T
Circ Cardiovasc Interv; 2023 May; 16(5):e012655. PubMed ID: 37192308
[TBL] [Abstract][Full Text] [Related]
9. Impact of leaflet thrombosis on valve haemodynamic status after transcatheter aortic valve replacement.
Jang MH; Ahn JM; Kang DY; Kim KW; Koo HJ; Yang DH; Jung SC; Kim B; Wong YTA; Lam CCS; Yin WH; Wei J; Lee YT; Kao HL; Lin MS; Ko TY; Kim WJ; Kang SH; Ko E; Lee SA; Kim DH; Kim H; Choi Y; Lee J; Park SJ; Park DW
Heart; 2023 Dec; 110(2):140-147. PubMed ID: 37586823
[TBL] [Abstract][Full Text] [Related]
10. Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study.
Blanke P; Leipsic JA; Popma JJ; Yakubov SJ; Deeb GM; Gada H; Mumtaz M; Ramlawi B; Kleiman NS; Sorajja P; Askew J; Meduri CU; Kauten J; Melnitchouk S; Inglessis I; Huang J; Boulware M; Reardon MJ;
J Am Coll Cardiol; 2020 May; 75(19):2430-2442. PubMed ID: 32234463
[TBL] [Abstract][Full Text] [Related]
11. Randomized Trial of Aspirin Versus Warfarin After Transcatheter Aortic Valve Replacement in Low-Risk Patients.
Rogers T; Shults C; Torguson R; Shea C; Parikh P; Bilfinger T; Cocke T; Brizzio ME; Levitt R; Hahn C; Hanna N; Comas G; Mahoney P; Newton J; Buchbinder M; Moreno R; Zhang C; Craig P; Asch FM; Weissman G; Garcia-Garcia HM; Ben-Dor I; Satler LF; Waksman R
Circ Cardiovasc Interv; 2021 Jan; 14(1):e009983. PubMed ID: 33423540
[TBL] [Abstract][Full Text] [Related]
12. Anatomical Characteristics Associated With Hypoattenuated Leaflet Thickening in Low-Risk Patients Undergoing Transcatheter Aortic Valve Replacement.
Khan JM; Rogers T; Weissman G; Torguson R; Rodriguez-Weisson FJ; Chezar-Azerrad C; Greenspun B; Gupta N; Medvedofsky D; Zhang C; Gordon P; Ehsan A; Wilson SR; Goncalves J; Levitt R; Hahn C; Parikh P; Bilfinger T; Butzel D; Buchanan S; Hanna N; Garrett R; Shults C; Buchbinder M; Garcia-Garcia HM; Kolm P; Satler LF; Hashim H; Ben-Dor I; Asch FM; Waksman R
Cardiovasc Revasc Med; 2021 Jun; 27():1-6. PubMed ID: 33129688
[TBL] [Abstract][Full Text] [Related]
13. Subclinical leaflet thrombosis after transcatheter aortic valve implantation is associated with silent brain injury on brain magnetic resonance imaging.
Apor A; Bartykowszki A; Szilveszter B; Varga A; Suhai FI; Manouras A; Molnár L; Jermendy ÁL; Panajotu A; Turáni MF; Papp R; Karády J; Kolossváry M; Kováts T; Maurovich-Horvat P; Merkely B; Nagy AI
Eur Heart J Cardiovasc Imaging; 2022 Nov; 23(12):1584-1595. PubMed ID: 36168113
[TBL] [Abstract][Full Text] [Related]
14. Effect of concomitant aortic regurgitation on early hypo-attenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
Xiong TY; Liao YB; Li YJ; Chen F; Li X; Wang ZJ; Wang X; Ou Y; Li Q; Wei JF; Peng Y; Meng W; Feng Y; Chen M
Catheter Cardiovasc Interv; 2020 Dec; 96(7):1491-1497. PubMed ID: 32400115
[TBL] [Abstract][Full Text] [Related]
15. The impact of hypo-attenuated leaflet thickening on haemodynamic valve deterioration following transcatheter aortic valve replacement.
Rashid HN; Michail M; Ramnarain J; Nasis A; Nicholls SJ; Cameron JD; Gooley RP
J Cardiovasc Comput Tomogr; 2022; 16(2):168-173. PubMed ID: 34852974
[TBL] [Abstract][Full Text] [Related]
16. Hypoattenuated Leaflet Thickening After Implantation of the ACURATE neo or the ACURATE neo2 Transcatheter Heart Valve.
Brunner S; Brinkert M; Moccetti F; Loretz L; Fornaro J; Stämpfli SF; Attinger-Toller A; Bossard M; Buhmann R; Cuculi F; Wolfrum M; Toggweiler S
Am J Cardiol; 2023 Aug; 200():146-152. PubMed ID: 37321028
[TBL] [Abstract][Full Text] [Related]
17. Quantification of hypo-attenuated leaflet thickening after transcatheter aortic valve implantation: clinical relevance of hypo-attenuated leaflet thickening volume.
Karády J; Apor A; Nagy AI; Kolossváry M; Bartykowszki A; Szilveszter B; Simon J; Molnár L; Jermendy ÁL; Panajotu A; Suhai FI; Varga A; Rajani R; Maurovich-Horvat P; Merkely B
Eur Heart J Cardiovasc Imaging; 2020 Dec; 21(12):1395-1404. PubMed ID: 32756984
[TBL] [Abstract][Full Text] [Related]
18. Subclinical leaflet thrombosis following transcatheter aortic valve replacement.
Kanjanauthai S; Pirelli L; Nalluri N; Kliger CA
J Interv Cardiol; 2018 Oct; 31(5):640-647. PubMed ID: 29790209
[TBL] [Abstract][Full Text] [Related]
19. Impact of On-Clopidogrel Platelet Reactivity on Incidence of Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve Replacement.
Nührenberg TG; Hromek J; Kille A; Hochholzer W; Hein M; Trenk D; Neumann FJ; Stratz C; Ruile P
JACC Cardiovasc Interv; 2019 Jan; 12(1):12-18. PubMed ID: 30621972
[TBL] [Abstract][Full Text] [Related]
20. Baseline global longitudinal strain by computed tomography is associated with post transcatheter aortic valve replacement outcomes.
Fukui M; Xu J; Thoma F; Sultan I; Mulukutla S; Elzomor H; Lee JS; Gleason TG; Cavalcante JL
J Cardiovasc Comput Tomogr; 2020; 14(3):233-239. PubMed ID: 31836414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
